Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

With the <keyword id="6356311" type="General" weightage="50" keywordseo="world-health-organisation" source="Orion">World Health Organisation</keyword> (WHO) declaring that Covid-19 is no longer a global emergency, medical device companies are likely to see a decrease in sales, according to a report on Tuesday. In the last three years of the pandemic, many medical device companies made billions through tests and pharmaceuticals. The report by data and analytics company <keyword id="1670029" type="General" weightage="80" keywordseo="globaldata" source="Orion">GlobalData</keyword> predicts that in the coming years, fewer new Covid-19 tests will be hitting the market; instead, existing tests will be improved. This could mean improving tests' specificity and sensitivity and creating multiparameter tests with existing technology. "Companies have reported decreasing sales of Covid-19 related products for the past two quarters. Therefore, having the Covid-19 pandemic declared over and instead an endemic virus, and with the emergency use authorisations on Covid-19 tests lifted, in vitro diagnostics (<keyword id="3175247" type="General" weightage="80" keywordseo="ivd" source="Orion">IVD</keyword>) companies are scrambling to minimise their losses," said <keyword id="17367396" type="General" weightage="50" keywordseo="selena-yu" source="Orion">Selena Yu</keyword>, <keyword id="17367395" type="General" weightage="50" keywordseo="medical-analyst" source="Orion">Medical Analyst</keyword> at GlobalData, in a statement. In vitro diagnostics (IVD) are tests done on samples such as blood or tissue that have been taken from the human body. Currently, there are 132 active clinical trials, out of 310 trials on infectious disease IVD devices, developing Covid-19 tests. In January 2023, many companies involved in Covid-19 tests, like <keyword id="229225" type="General" weightage="50" keywordseo="danaher" source="Orion">Danaher</keyword>, <keyword id="48168" type="General" weightage="20" keywordseo="abbott" source="Orion">Abbott</keyword>, <keyword id="248095" type="General" weightage="50" keywordseo="labcorp" source="Orion">Labcorp</keyword>, and Becton, <keyword id="292392" type="General" weightage="20" keywordseo="dickinson" source="Orion">Dickinson</keyword> and Company, also known as BD, made statements on their significant drops in Covid-19 tests. "Now that the pandemic has been announced to no longer be an emergency, the drops will become more significant in the coming months. There could be peak sales in the fall and winter seasons as the respiratory disease season starts up again," Yu said. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/apps/news/jamtara-global-indian-whatsapp-users-flooded-with-spam-calls/articleshow/100103446.cms">'Jamtara Global': Indian WhatsApp users flooded with spam calls</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/condom-maker-mankind-pharma-lists-at-20-premium-beats-grey-market-expectations/articleshow/100090002.cms">Mankind Pharma stock runs up in trade after listing at 20% premium</a>

You Searched For "selena yu" and got 1 results

End of Covid emergency to affect sales of diagnostics cos: GlobalData report

IANS

Popular Keywords

Buying Guides